Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1974 Dec;10(6):1356–1361. doi: 10.1128/iai.10.6.1356-1361.1974

Type-Specific Opsonic Antibodies in Streptococcal Pyoderma

Alan L Bisno 1,2,3, Kenrad E Nelson 1,2,3
PMCID: PMC423111  PMID: 4435959

Abstract

Prospective studies of streptococcal pyoderma were carried out among black children enrolled in Project Headstart centers in Holmes County, Miss. Sera collected from 28 of these children in early October were tested for opsonic antibodies to one of two prevalent skin strains of group A streptococci isolated from them on one or more occasions over the preceding 3 months. The two streptococcal strains (A and B) belong to M-types previously unrecognized. Ten subjects (36%) had antibody to their homologous serotypes detectable by the indirect bactericidal test: this included 6 of 10 subjects infected with strain B but only 4 of 18 infected with strain A (P < 0.05). Of 17 children who had strains A or B isolated from skin lesions only, 12% developed type-specific antibodies (TSA) against the infecting serotype. In contrast, 11 subjects had these strains isolated from throat cultures (either with or without associated pyoderma), and 72% had detectable TSA (P < 0.01). There was no demonstrable relationship between the development of antibodies to streptococcal extracellular products or to non-type-specific cellular antigens and the development of TSA. These results demonstrate that type-specific immune responses do occur following infection with pyoderma streptococci. The frequency with which such antibodies develop is variable and appears related to a number of factors, including the immunologic properties of the infecting strain and the site of bacterial colonization. Pharyngeal carriage may represent an important mechanism for development of acquired immunity to skin strains of group A streptococci.

Full text

PDF
1356

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen A. M., Taplin D., Twigg L. Cutaneous streptococcal infections in Vietnam. Arch Dermatol. 1971 Sep;104(3):271–280. [PubMed] [Google Scholar]
  2. Beachey E. H., Ofek I., Bismo A. L. Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. J Immunol. 1973 Nov;111(5):1361–1366. [PubMed] [Google Scholar]
  3. Beachey E. H., Ofek I., Cunningham M., Bisno A. Evaluation of micro complement fixation tests for antibodies against group A streptococcal M and M-associated antigens in rabbit and human sera. Appl Microbiol. 1974 Jan;27(1):1–4. doi: 10.1128/am.27.1.1-4.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bergner-Rabinowitz S., Ofek I., Davies M. A., Rabinowitz K. Type-specific streptococcal antibodies in pyodermal nephritis. J Infect Dis. 1971 Nov;124(5):488–493. doi: 10.1093/infdis/124.5.488. [DOI] [PubMed] [Google Scholar]
  5. Bisno A. L., Nelson K. E., Waytz P., Brunt J. Factors influencing serum antibody responses in streptococcal pyoderma. J Lab Clin Med. 1973 Mar;81(3):410–420. [PubMed] [Google Scholar]
  6. Bisno A. L., Svartman M., Stollerman G. H. Cross-reacting and monotypic T antigens of nephritogenic pyoderma streptococci: the type 56 system. J Immunol. 1971 Jun;106(6):1493–1498. [PubMed] [Google Scholar]
  7. Cunningham M. W., Beachey E. H. Peptic digestion of streptococcal M protein. I. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts. Infect Immun. 1974 Feb;9(2):244–248. doi: 10.1128/iai.9.2.244-248.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DAIKOS G., WEINSTEIN L. Streptococcal bacteriostatic antibody in patients treated with penicillin. Proc Soc Exp Biol Med. 1951 Oct;78(1):160–163. doi: 10.3181/00379727-78-19007. [DOI] [PubMed] [Google Scholar]
  9. DENNY F. W., Jr, PERRY W. D., WANNAMAKER L. W. Type-specific streptococcal antibody. J Clin Invest. 1957 Jul;36(7):1092–1100. doi: 10.1172/JCI103504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kuttner A. G., Lenert T. F. THE OCCURRENCE OF BACTERIOSTATIC PROPERTIES IN THE BLOOD OF PATIENTS AFTER RECOVERY FROM STREPTOCOCCAL PHARYNGITIS. J Clin Invest. 1944 Mar;23(2):151–161. doi: 10.1172/JCI101478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LANCEFIELD R. C. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med. 1957 Oct 1;106(4):525–544. doi: 10.1084/jem.106.4.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LANCEFIELD R. C. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med. 1959 Aug 1;110(2):271–292. doi: 10.1084/jem.110.2.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MOODY M. D., PADULA J., LIZANA D., HALL C. T. EPIDEMIOLOGIC CHARACTERIZATION OF GROUP A STREPTOCOCCI BY T-AGGLUTINATION AND M-PRECIPITATION TESTS IN THE PUBLIC HEALTH LABORATORY. Health Lab Sci. 1965 Jul;2:149–162. [PubMed] [Google Scholar]
  14. POTTER E. V., STOLLERMAN G. H., SIEGEL A. C. Recall of type specific antibodies in man by injections of streptococcal cell walls. J Clin Invest. 1962 Feb;41:301–310. doi: 10.1172/JCI104483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Potter E. V., Ortiz J. S., Sharrett A. R., Burt E. G., Bray J. P., Finklea J. F., Poon-King T., Earle D. P. Changing types of nephritogenic streptococci in Trinidad. J Clin Invest. 1971 Jun;50(6):1197–1205. doi: 10.1172/JCI106597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. STOLLERMAN G. H., KANTOR F. S., GORDON B. D. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods. J Exp Med. 1958 Oct 1;108(4):475–491. doi: 10.1084/jem.108.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Vosti K. L., Johnson R. H., Dillon M. F. Further characterization of purified fractions of M protein from a strain of group A, type 12 Streptococcus. J Immunol. 1971 Jul;107(1):104–114. [PubMed] [Google Scholar]
  18. Widdowson J. P., Maxted W. R., Pinney A. M. An M-associated protein antigen (MAP) of group A streptococci. J Hyg (Lond) 1971 Dec;69(4):553–564. doi: 10.1017/s0022172400021823. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES